Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P14784 (
IL-2 receptor
)
3,849
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A growth-inhibitory substance found in the culture of a B-precursor leukemia cell line, NALM-20, was purified from the serum-free culture medium and identified as
arginine deiminase
derived from Mycoplasma arginini (
EC 3.5.3.6
). Arginine deiminase strongly inhibited, in a dose-dependent manner, the growth of human T cells and T lymphoblastoid cell lines, but not that of B-precursor and myeloid cell lines. The addition of L-arginine completely restored the growth of T lymphoblastoid cells that had been inhibited by
arginine deiminase
. The addition of L-ornithine also partially restored it. This enzyme suppressed interleukin-2 (IL-2) production and
IL-2 receptor
expression in T cells stimulated by non-specific mitogens. The morphologic features of dying cells and DNA fragmentation indicated that
arginine deiminase
induced apoptotic cell death in T lymphoblasts. Cell cycle analysis revealed that G1-->S transition was blocked in cell treated with
arginine deiminase
, accompanied by the increase of apoptotic nuclei in the sub-G1 fraction. In conclusion, the deletion of the essential nutrient L-arginine by
arginine deiminase
significantly inhibited cell growth and activation in T lymphoblasts, accompanied by the induction of apoptotic cell death.
...
PMID:Apoptotic cell death of human T lymphoblastoid cells induced by arginine deiminase. 907 17